Osteoporosis Treatment Market Size, Share, Outlook, and Opportunity Analysis, 2018 – 2026

1. OSTEOPOROSIS TREATMENT MARKET ANALYSIS INDUSTRY INSIGHTS, TRENDS, OUTLOOK, AND OPPORTUNITY ANALYSIS, 2020–2027 © Coherent market Insights. All Rights Reserved © Coherent market Insights. All Rights Reserved

2. REPORT DESCRIPTION Osteoporosis Treatment- Overview Osteoporosis Treatment Market, by Drug Type (Bisphosphonates (Alendronate, Risedronate, Ibandronate, Zoledronic Acid, and Others), Calcitonin, Hormone Therapy, Selective Estrogen Receptor Modulators (SERMs), Parathyroid Hormone- Related Protein (PTHrP) Analog, and Rank Ligand (RANKL) Inhibitor), by Route of Administration (Oral, Injectable, and Others), by Distribution Channel (Hospital, Retail Pharmacies, and Online Pharmacies), and by Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Size, Share, Outlook, and Opportunity Analysis, 2018-2026 Osteoporosis is characterized by reduction in the density and quality of bones that often result in broken bones in the wrist, hip, and spine. Various factors responsible for osteoporosis include genetic factors, low intake of calcium, magnesium, and vitamin D, eating disorders such as anorexia, inactivity and immobility, and excessive alcohol intake. Moreover, conditions that increase the risk of osteoporosis include cancer, chronic kidney diseases, chronic obstructive pulmonary disease, and some autoimmune disease such as rheumatoid arthritis. Browse Research Reports: https://www.coherentmarketinsights.com/market- insight/osteoporosis-treatment-market-1096 © Coherent market Insights. All Rights Reserved

3. REPORT DESCRIPTION The global osteoporosis treatment market size was valued at US$ 11.8 Bn in 2017, and is expected to exhibit a CAGR of 3.8% over the forecast period (2018-2026). Increasing incidence of osteoporosis with rising geriatric population is expected to drive demand for osteoporosis treatment drugs High prevalence and increased diagnosis of osteoporosis in geriatric population is expected to rise demand for osteoporosis drugs and fuel the osteoporosis treatment market growth. For instance, according to a report by United Nations Economic and Social Commission for Asia and the Pacific (ESCAP) in 2016, Asia Pacific constituted around 60% of the world’s geriatric population. Furthermore, key players are involved in strategic agreement for the development of novel osteoporosis drugs to launch in the market. For instance, in June 2018, Pfenex Inc. and Alvogen Inc. entered into strategic agreement for the development of Pfenex Inc.’s osteoporosis drug candidate PF708. According to the agreement, Pfenex’s granted exclusive rights to commercialize PF708 to Alvogen Inc. Asia Pacific osteoporosis treatment market is expected to witness significant growth over the forecast period, owing to increasing strategic collaboration of key players with Asia Pacific companies for penetrating key regions in Asia Pacific and to expand its product presence. Request a Sample copy of this reports :https://www.coherentmarketinsights.com/insight/request-sample/1096 © Coherent market Insights. All Rights Reserved

4. REPORT DESCRIPTION Europe osteoporosis treatment market is expected to witness significant growth over the forecast period, owing to the penetration of key players in the region and focus of key players to receive approval for its new osteoporosis drugs in the market. However, launch of generic versions of osteoporosis drugs is expected to restrain revenue growth of the osteoporosis treatment market, owing to low price of generic drugs as compared to branded. For instance, in 2015, Teva Pharmaceutical Industries Ltd. launched generic version of Actonel (risedronate sodium) Tablets, 5 mg, 30 mg, and 35 mg in the U.S. market. In 2012, Dr. Reddy's Laboratories launce its generic anti- osteoporosis drug Ibandronate Sodium, in 2012 Mylan Inc. received U.S. Food and Drug Administration approval for Ibandronate Sodium Tablets, 150mg, a generic version of F. Hoffmann-La Roche AG’s Boniva indicated for treatment of osteoporosis in postmenopausal women. Key players operating in the global osteoporosis treatment market include Teva Pharmaceutical Industries Ltd., Daiichi Sankyo Company Limited, Amgen Inc., Dr. Reddy's Laboratories, Mylan Inc., Pfenex Inc., Eli Lilly and Company, Asahi Kasei Corporation, F.Hoffmann La Roche AG, EffRx Pharmaceuticals SA, Novartis AG, Merck & Co AG, GlaxoSmithKline Plc., Allergan plc., and Pfizer Inc. Buy-Now this Research Report @ https://www.coherentmarketinsights.com/insight/buy-now/1096 © Coherent market Insights. All Rights Reserved

5. ABOUT COHERENT MARKET INSIGHTS ABOUT US Coherent Market Insights is a global market intelligence and consulting organization focused on assisting its plethora of clients achieve transformational growth by helping them make critical business decisions. We are headquartered in India, with an office at the global financial capital in the U.S. Our client base includes players from across all business verticals in over 150 countries worldwide. We are uniquely positioned to help businesses around the globe deliver practical and lasting results through various recommendations about operational improvements, technologies, emerging market trends and new working methods. We offer both customized and syndicated market research reports that help our clients create visionary growth plans to provide traction to their business. We meticulously study emerging trends across various industries at both the global and regional levels to identify new opportunities for our clientele. SERVICES CUSTOMIZED RESEARCH INDUSTRY ANALYSIS SYNDICATED RESEARCH COUNTRY SPECIFIC STUDIES MARKET INTELLIGENCE SERVICES CONSULT STUDIES © Coherent market Insights. All Rights Reserved

6. ABOUT CMI SECTOR COVERAGE BIOTECHNOLOGY CLINICAL DIAGNOSTIC HEALTHCARE IT MEDICAL DEVICES MEDICAL IMAGING PHARMACEUTICAL OUR CLIENTS  Global Leading Equipment and System Manufacturers  Marketing Consultancies and the Advertising Industry  Component Providers and System Integrators  Private and Government organization  Distributors, Retailors and Value Added Resellers  Outsourcing Companies  Healthcare IT Solutions Developers  Universities and Business Schools. © Coherent market Insights. All Rights Reserved

7. KEY STATS RESEARCH SOLUTIONS 100+ GLOBAL REPORTS FEASIBILITY STUDIES Insights Published Per Year CUSTOMIZED SOLUTIONS 150+ COUNTRY ANALYSIS Consulting Projects Till Date CONSULT PROJECTS SURVEY RESEARCH 125+ EXCEL FORECAST DATABASE Clients Worldwide Per Year COMPETITIVE ASSESSMENT TECHNOLOGY SNIPPETS 110+ Analysts and Contract Consultants Coherent Market Insights excels at offering unmatched actionable market intelligence across various industry verticals, including chemicals, healthcare, and food & beverages, to name a few. We implement holistic market research methodology in order to result in the best possible market research reports across various industries worldwide. Based on our unmatched expertise across various industries—no matter how large or small, how complex or unique—we help our clients achieve better outcomes with uniquely designed and highly customized solutions. Our coverage includes insights that help our clients ensure sustained growth in developed markets and also key inputs to help them tap into emerging markets and exploit the plethora of opportunities posed therein. © Coherent market Insights. All Rights Reserved

8. THANK YOU To know more about us, visit our website: www.coherentmarketinsights.com For sales queries or new topics email us on: sales@coherentmarketinsights.com For other queries contact: Mr. Shah (Manager - Business Development) Coherent Market Insights sales@coherentmarketinsights.com +1-206-701-6702 © Coherent market Insights. All Rights Reserved